ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Research
Public health
Medicine / Sub specialtie
Chemistry
Technology
Pure sciences
Economy
Medicine / Pharmacology
Agronomy and forestry
Biology
all records (13)

Languages
English
Spanish

Countries
Croatia
Colombia
Indonesia
Italy
USA
India
Macedonia
Morocco
Pakistan
Peru

Years
2021
2020
2019
2018
2017
2016
2015
2013

Filter  
 
18  Articles
1 of 3 pages  |  10  records  |  more records»
Objective: To evaluate the clinical effects of erlotinib combined with concurrent chemoradiotherapy in the treatment of locally advanced pancreatic cancer.Methods: Eighty patients with locally advanced pancreatic cancer who attended Shijiazhuang People’s ... see more

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related dead worldwide and accounts for over 85% of all lung cancers. Furthermore, the majority of patients with NSCLC present with advanced, metastatic disease at the time of diagnosis. Fo... see more

Protein tyrosine kinases form an important target for a new class of anticancer drugs, the tyrosine kinase inhibitors (TKIs). Recently we demonstrated that sunitinib, an inhibitor of the membrane-associated vascular endothelial growth factor receptor (VEG... see more

s-

To explore the effectiveness and possible toxicity of the use of epidermal growth factor receptor inhibitor (EGFR Inhibitor), Celecoxib (COX2 inhibitor) and Sirolimus (m-TOR inhibitor) as single agents and drug combinations for the treatment of lung cance... see more

Introducción: El cáncer de pulmón es el cáncer con mayor mortalidad en ambos sexos. El esquema de manejo actual del adenocarcinoma pulmonar incluye determinar el estado mutacional del receptor del factor de crecimiento epidérmico (EGFR), por ser la diana ... see more

El Cáncer Hepático o Carcinoma Hepatocelular (HCC) y el Cáncer de Seno Triple Negativo (por sus siglas en inglés TNBC, Triple Negative Breast Cancer), son problemas de salud pública en el mundo, por su difícil tratamiento y alta resistencia a la quimioter... see more

Transport of erlotinib, gefitinib, sorafenib, sunitinib, dasatinib and crizotinib can be active or passive, which was studied by measuring uptake  at low (4 °C; passive) and normal temperature (37 °C; active and passive) and by the use of specific or... see more

Tyrosine and aurora kinases are important effectors in signal transduction pathways that are often involved in aberrant cancer cell growth. Tyrosine (TKI) and aurora (AKI) kinase inhibitors are anti-cancer agents specifically designed to target such signa... see more

1 of 3 pages  |  10  records  |  more records»